Avantis vs Injective — how do they compare? Avantis trades at Rp1,918 (market cap Rp655,06M, Rp675,62M 24h volume), while Injective trades at Rp75,988 (market cap Rp7,68T, Rp1,11T 24h volume). The key difference: Injective is far larger — about 11724.1× Avantis's market cap, and Avantis's supply is capped (339M / 1B AVNT (34%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Avantis for 21 Days and Injective for 37 Days on average.
| AVNT | INJ | |
|---|---|---|
Market Cap | Rp655,06M | Rp7,68T |
Volume (24h) | Rp675,62M | Rp1,11T |
Circulating Supply | 339M / 1B AVNT (34%) | 100M INJ |
Typical Hold Time | 21 Days | 37 Days |
Signals from Pluang's Aura AI — not financial advice
Avantis (AVNT) is trading at Rp1,957 with a market cap of Rp647.99M, showing bullish technical signals across moving averages and oscillators. The token is currently trading near its pivot point of Rp1,875 with strong support at Rp1,676 and resistance at Rp2,133. With 34% of the 1M max supply in circulation and an average hold time of 22 days, the token demonstrates moderate distribution and holding patterns.
Overall outlook remains cautiously optimistic with technical indicators supporting bullish momentum, though RSI levels above 80 suggest potential overbought conditions. Key opportunities include continued technical strength and network growth, while risks include high volatility and regulatory uncertainty typical of cryptocurrency assets.
Injective (INJ) is currently trading at Rp75,554 with a market cap of Rp7.49T, exhibiting a bearish technical signal as indicated by moving averages. The asset trades below its pivot point of Rp82,186, with key support at Rp81,456 and resistance at Rp82,576. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding behavior.
The overall outlook is cautious due to bearish technical indicators and neutral oscillators. Key opportunities lie in potential rebounds from support levels, while major risks include high volatility and the absence of recent significant protocol updates. Investors should monitor trading volume and broader crypto market trends closely.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Avantis is the largest RWA perpetuals DEX in DeFi, built on Base. It enables users to trade crypto and real-world assets such as FX, commodities, indices, and equities. Supported by Pantera and Coinbase, Avantis combines institutional-grade products with the transparency and accessibility of DeFi, offering leverage up to 500x.
Read more on AVNT →Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →